Ex-Tennis Australia director Harold Mitchell, facing enforcement action by ASIC alleging he breached his duties in awarding Australian Open broadcast rights to the Seven Network, has asked a court for all evidence the regulator obtained from former board member Graeme Holloway, who died in February.
A judge has given the all-clear to an investment management company to access evidence for potential legal action against the National Stock Exchange of Australia after the firm’s shares were suspended without warning or explanation.
Rural supply giant Landmark’s has offered to sell three stores to win Australian Competition and Consumer Commission approval for its proposed $469 million takeover of competitor Ruralco, a move that would consolidate two of the three largest players in the rural merchandise market.
The government has thrown its weight behind the Australian Competition and Consumer Commission’s call for checking the power of Facebook and Google, in a long-awaited final report that recommends a sweep of measures to crack down on the digital giants, and extend well beyond them.
The Australian Competition and Consumer Commission has expressed competition concerns about ANZ Terminals’ proposed acquisition of a unit of global agribusiness GrainCorp, despite the storage specialist offering to divest one of its terminals to win approval for the $350 million deal.
Mylan and Cipla have reached a speedy resolution of a consumer lawsuit accusing Cipla of copying the get-up of Mylan’s blockbuster cholesterol drug Lipidil.
Construction giant Lendlease faces a second shareholder class action over market disclosures relating to its underperforming engineering division, and joining the case is one of the biggest public pension funds in the US.
A catfight has broken out between construction equipment and workwear maker Caterpillar and sneaker giant Puma, with Caterpillar arguing Puma’s ‘procat’ trade mark is deceptively similar to its ‘cat’ marks.
Certain executives of Australian companies might have to wait seven years to have their bonuses paid out under proposed changes to executive remuneration introduced by the Australian Prudential Regulation Authority designed to limit the risk of misconduct and align executive pay with long-term performance.
Mylan has launched a lawsuit against Cipla for allegedly copying the get-up of its blockbuster cholesterol drug Lipidil, after losing a bid to block Cipla and Sun Pharma from selling generic versions of the drug while it appeals a ruling invalidating several claims of its patents.